Bcl-xL inhibits PINK1/Parkin-dependent mitophagy by preventing mitochondrial Parkin accumulation

Area of Science:

• Cell Biology
• Mitochondrial Dynamics
• Protein Interactions

Background:

• Mitophagy is a crucial cellular process for removing damaged mitochondria.
• The PINK1/Parkin pathway is a key regulator of mitophagy.
• Bcl-2 family proteins, like Bcl-xL, are known regulators of apoptosis and mitochondrial function.

Purpose of the Study:

• To investigate the role of Bcl-xL in regulating PINK1/Parkin-dependent mitophagy.
• To elucidate the molecular mechanisms by which Bcl-xL affects mitophagy.

Main Methods:

• Co-expression of Bcl-xL and Parkin in Hela cells.
• Carbonyl cyanide 3-chlorophenylhydrazone (CCCP)-induced mitophagy.
• Western blotting for mitochondrial protein levels.
• Fluorescence loss in photobleaching (FLIP) for Parkin translocation.
• Fluorescence resonance energy transfer (FRET) imaging for protein interactions.
• Analysis in HEK293 T cells for endogenous protein interactions.

Main Results:

• Bcl-xL significantly inhibited CCCP-induced Parkin accumulation and mitophagy.
• Over-expressed Bcl-xL prevented the decrease of mitochondrial proteins during mitophagy.
• Bcl-xL inhibited Parkin translocation to mitochondria without affecting its retrotranslocation.
• Bcl-xL directly interacted with Parkin in the cytoplasm and PINK1 on mitochondria.
• Endogenous Bcl-xL, Parkin, and PINK1 were found to interact in HEK293 T cells.

Conclusions:

• Bcl-xL inhibits PINK1/Parkin-dependent mitophagy.
• Bcl-xL prevents Parkin accumulation on mitochondria by binding Parkin in the cytoplasm.
• Bcl-xL further inhibits mitophagy by binding PINK1 on mitochondria, thereby blocking Parkin translocation.